The function of miRNA in cardiac hypertrophy

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Epigenetics

Background:

• Cardiac hypertrophy, the enlargement of heart muscle, is a response to stress that can lead to heart failure if pathological.
• MicroRNAs (miRNAs) are key regulators of gene expression, influencing cellular processes.
• Aberrant miRNA expression is linked to pathological cardiac hypertrophy and heart failure in various models.

Purpose of the Study:

• To review the cell-autonomous roles of cardiomyocyte miRNAs in cardiac hypertrophy.
• To examine the involvement of non-cardiomyocyte miRNAs in the development of cardiac hypertrophy.
• To discuss the therapeutic potential of miRNAs in treating heart diseases.

Main Methods:

• Literature review synthesizing recent findings on miRNA function in cardiac hypertrophy.
• Analysis of studies investigating miRNA expression signatures in human and mouse heart disease models.
• Examination of research on signaling pathways and cellular responses modulated by miRNAs.

Main Results:

• Specific miRNAs are dysregulated in pathological cardiac hypertrophy and heart failure.
• miRNAs within cardiomyocytes and non-cardiomyocytes critically influence cellular responses to stress.
• Altered miRNA expression can drive the progression from cardiac hypertrophy to heart failure.

Conclusions:

• MicroRNAs are crucial regulators of cardiac homeostasis and pathological cardiac hypertrophy.
• Targeting specific miRNAs presents a promising therapeutic strategy for heart failure.
• Further research into miRNA mechanisms can elucidate novel treatments for cardiovascular diseases.